INDICATION
Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions.
IMPORTANT SAFETY CONSIDERATIONS
Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them.
INDICATION
Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions. Perfectha is for intradermal and subcutaneous application and is implanted in the areas of the face and hands to fill skin depressions and also for the augmentation of tissue volume.
IMPORTANT SAFETY CONSIDERATIONS
Like all procedures of this type, there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules, etc.), pain (which may be temporary or persistent in nature), transient hematoma or bruising. For a full list consult Instructions for Use.
The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Perfectha distributor. Alternatively send the details to Sinclair on: quality@sinclair.com
For a full list of contraindications, warnings, and precautions for this product please visit eifu.sinclairpharma.com for a copy of the Product Instructions for Use.